Go Pro

Kymera Therapeutics (KYMR) Institutional Ownership

Kymera Therapeutics logo
$118.48 +2.15 (+1.85%)
Closing price 09/17/2026 04:00 PM Eastern
Extended Trading
$118.58 +0.10 (+0.08%)
As of 09:13 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Kymera Therapeutics (NASDAQ:KYMR)

Number of
Institutional Buyers
(last 12 months)
162
Total
Institutional Inflows
(last 12 months)
$1.83B
Number of
Institutional Sellers
(last 12 months)
71
Total
Institutional Outflows
(last 12 months)
$732.74M
Get KYMR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Kymera Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

KYMR Institutional Buying and Selling by Quarter

Kymera Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/9/2026 Squarepoint Ops LLC97,189$11.15M0.0%+657.0%0.117%
9/8/2026 Arizona State Retirement System12,390$1.42M0.0%-5.5%0.015%
9/8/2026 Nykredit A S1,807$207K0.0%N/A0.002%
9/2/2026 Allianz Asset Management GmbH4,500$516K0.0%N/A0.005%
8/25/2026 VIRGINIA RETIREMENT SYSTEMS ET Al3,000$344K0.0%N/A0.004%
8/23/2026 DMC Group LLC2,000$229K0.2%N/A0.002%
8/21/2026 Atlas Venture Life Science Advisors LLC2,847,541$326.53M37.1%-37.8%3.425%
8/21/2026 Braidwell LP378,163$43.36M1.6%+12.0%0.455%
8/21/2026 Nykredit A S1,807$207K0.0%N/A0.002%
8/20/2026 Proficio Capital Partners LLC11,045$1.27M0.0%+1.8%0.013%
8/20/2026 Yiheng Capital Management L.P.63,440$7.28M2.5%-13.6%0.076%
8/20/2026 Two Sigma Securities LLC2,716$311K0.0%N/A0.003%
8/20/2026 Alyeska Investment Group L.P.276,455$31.70M0.1%-19.3%0.332%
8/19/2026 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC736,866$84.50M0.0%-15.9%0.886%
8/19/2026 Wellington Management Group LLP3,675,028$421.42M0.1%-5.5%4.420%
8/18/2026 Beacon Pointe Advisors LLC2,301$264K0.0%N/A0.003%
8/18/2026 Empowered Funds LLC2,338$268K0.0%N/A0.003%
8/17/2026 Proficio Capital Partners LLC11,045$1.27M0.0%N/A0.013%
8/17/2026 Bamco Inc. NY20,000$2.29M0.0%N/A0.024%
8/17/2026 Bank of America Corp DE378,286$43.38M0.0%N/A0.455%
8/17/2026 Boone Capital Management LLC113,173$12.98M3.0%N/A0.136%
8/15/2026 Freestone Grove Partners LP21,176$2.43M0.0%N/A0.025%
8/15/2026 Odyssean LLC34,485$3.95M0.6%+132.7%0.041%
8/15/2026 Man Group plc19,085$2.19M0.0%N/A0.023%
8/15/2026 Jupiter Topco LLC21,058$2.42M0.0%N/A0.025%
8/14/2026 Nicholas Investment Partners LP54,569$6.26M0.4%N/A0.066%
8/14/2026 Legal & General Group Plc36,237$4.16M0.0%N/A0.044%
8/14/2026 The Manufacturers Life Insurance Company119,503$13.70M0.0%N/A0.144%
8/14/2026 Brandywine Managers LLC7,570$868K0.4%N/A0.009%
8/14/2026 Nan Fung Group Holdings Ltd30,875$3.54M0.0%N/A0.037%
8/14/2026 Algert Global LLC3,430$393K0.0%-29.0%0.004%
8/13/2026 Connor Clark & Lunn Investment Management Ltd.149,908$17.19M0.0%N/A0.180%
8/11/2026 B. Metzler seel. Sohn & Co. AG12,083$1.39M0.0%N/A0.015%
8/11/2026 E Fund Management Co. Ltd.5,209$597K0.0%N/A0.006%
8/10/2026 Eagle Health Investments LP166,148$19.05M3.2%N/A0.200%
8/7/2026 Merck & Co. Inc.772,165$88.54M0.0%N/A0.939%
8/7/2026 BlackRock Inc.5,538,210$635.07M0.0%N/A6.733%
8/7/2026 Deutsche Bank AG106,049$12.16M0.0%N/A0.129%
8/7/2026 TimesSquare Capital Management LLC157,327$18.04M0.3%N/A0.191%
8/6/2026 Bank of New York Mellon Corp215,588$24.72M0.0%N/A0.262%
The national debt just passed $39 trillion (Ad)

The U.S. national debt just topped $39 trillion, up nearly $3 trillion in a single year and on pace to hit $40 trillion by fall. Servicing that debt now costs more than the entire defense budget, while inflation above 3.5% keeps eroding cash savings. Central banks are responding by buying gold at the fastest pace in decades. The U.S. Gold Bureau's complimentary guide covers IRA-eligible gold and silver options, secure storage, and a fast BuyBack Guarantee.tc pixel

Claim your complimentary Gold IRA guide today
8/6/2026 State of Wyoming11,780$1.35M0.1%N/A0.014%
8/6/2026 GSA Capital Partners LLP7,343$842K0.1%N/A0.009%
7/10/2026 Handelsbanken Fonder AB20,700$2.37M0.0%+15.0%0.025%
7/7/2026 GAMMA Investing LLC454$52K0.0%+27.5%0.001%
6/16/2026 Empowered Funds LLC2,438$203K0.0%N/A0.003%
5/26/2026 Glenmede Trust Co. NA6,779$565K0.0%+3.6%0.008%
5/19/2026 Bank of America Corp DE289,416$24.11M0.0%-14.6%0.352%
5/18/2026 Amundi2,988$249K0.0%N/A0.004%
5/18/2026 California State Teachers Retirement System56,282$4.69M0.0%+23.0%0.068%
5/18/2026 Royal Bank of Canada730$60K0.0%-67.7%0.001%
5/18/2026 Eagle Health Investments LP145,816$12.15M2.1%+7.0%0.177%
5/18/2026 Empowered Funds LLC2,438$203K0.0%N/A0.003%
5/16/2026 The Manufacturers Life Insurance Company120,151$10.01M0.0%-11.6%0.146%
5/15/2026 Octagon Capital Advisors LP425,000$35.40M3.9%-20.6%0.517%
5/14/2026 Atlas Venture Life Science Advisors LLC4,578,008$381.30M48.3%-1.8%5.565%
5/14/2026 Siren L.L.C.3,186,830$265.43M7.4%-3.0%3.874%
5/14/2026 Inceptionr LLC3,618$301K0.1%N/A0.004%
5/14/2026 Sei Investments Co.11,225$935K0.0%-15.3%0.014%
5/14/2026 Monashee Investment Management LLC35,100$2.92M1.6%-64.9%0.043%
5/13/2026 Cetera Investment Advisers3,602$300K0.0%+7.5%0.004%
5/13/2026 First Trust Advisors LP93,617$7.80M0.0%+59.0%0.114%
5/8/2026 PNC Financial Services Group Inc.1,285$107K0.0%+56.3%0.002%
5/7/2026 WCM Investment Management LLC152,381$12.11M0.0%+44.9%0.185%
5/7/2026 Dimensional Fund Advisors LP592,879$49.36M0.0%-5.0%0.721%
5/7/2026 AlphaCentric Advisors LLC5,342$445K0.4%+6.1%0.006%
5/7/2026 Swiss National Bank94,500$7.87M0.0%+0.3%0.115%
5/6/2026 Jennison Associates LLC508,999$42.40M0.0%+2.5%0.619%
5/5/2026 Marks Group Wealth Management Inc4,003$333K0.0%N/A0.005%
5/5/2026 Bank of New York Mellon Corp193,200$16.09M0.0%+0.2%0.235%
5/4/2026 Principal Financial Group Inc.4,147$345K0.0%+24.4%0.005%
5/1/2026 Fifth Third Bancorp51,238$4.27M0.0%N/A0.063%
4/28/2026 Abel Hall LLC4,833$403K0.1%-17.2%0.006%
4/22/2026 Pictet Asset Management Holding SA468,728$38.76M0.0%-3.0%0.574%
4/20/2026 Keudell Morrison Wealth Management6,990$582K0.1%+5.9%0.009%
4/16/2026 SG Americas Securities LLC3,163$263K0.0%-86.1%0.004%
3/20/2026 Hsbc Holdings PLC7,619$597K0.0%-26.1%0.009%
3/17/2026 Rockefeller Capital Management L.P.25,533$1.99M0.0%+21,538.1%0.031%
3/3/2026 Caitong International Asset Management Co. Ltd2,542$198K0.0%N/A0.003%
2/23/2026 Virtu Financial LLC27,283$2.12M0.1%N/A0.038%
2/19/2026 T. Rowe Price Investment Management Inc.629,745$49.00M0.0%+3.0%0.875%
2/19/2026 Invesco Ltd.116,747$9.08M0.0%+46.3%0.162%
2/18/2026 Vident Advisory LLC7,581$590K0.0%+6.5%0.011%
2/18/2026 Mackenzie Financial Corp3,464$270K0.0%N/A0.005%
2/18/2026 XTX Topco Ltd24,143$1.88M0.0%N/A0.034%
2/18/2026 Yiheng Capital Management L.P.73,440$5.71M1.2%-40.1%0.102%
2/18/2026 Virtus Investment Advisers LLC2,966$231K0.1%+23.3%0.004%
2/18/2026 Wellington Management Group LLP4,412,933$343.37M0.1%-15.1%6.133%
2/18/2026 RTW Investments LP240,000$18.67M0.2%N/A0.334%
2/18/2026 Odyssean LLC9,347$727K0.5%N/A0.013%
2/18/2026 Perceptive Advisors LLC69,935$5.44M0.1%-58.8%0.097%
NVDA CEO says it’s a "once-in-a-generation opportunity" (Ad)

NVIDIA CEO Jensen Huang calls a little-known AI niche a once-in-a-generation opportunity, and it has nothing to do with chips or ChatGPT. Huang says AI is moving off computers and into the real world, calling it the dawn of a new industrial revolution. Matt McCall, who flagged NVDA at $6 before it climbed 3,100% in six years, reveals his top pick in this emerging space.tc pixel

See the full story and Matt McCall's number one pick now
2/18/2026 Millennium Management LLC11,243$875K0.0%-88.2%0.016%
2/18/2026 Man Group plc20,026$1.56M0.0%N/A0.028%
2/18/2026Janus Henderson Group PLC21,058$1.64M0.0%+15.0%0.029%
2/18/2026 Clough Capital Partners L P10,925$850K0.1%N/A0.015%
2/18/2026 Baker BROS. Advisors LP8,657,242$673.62M3.9%+30.2%12.032%
2/18/2026 Bamco Inc. NY20,000$1.56M0.0%+185.7%0.028%
2/18/2026 Armistice Capital LLC81,165$6.32M0.1%N/A0.113%
2/17/2026 Guggenheim Capital LLC10,307$802K0.0%N/A0.014%
2/17/2026 Logos Global Management LP130,000$10.12M0.6%-48.0%0.181%
2/17/2026 AQR Capital Management LLC9,339$727K0.0%+8.3%0.013%


KYMR Institutional Ownership - Frequently Asked Questions

During the previous two years, 252 institutional investors and hedge funds held shares of Kymera Therapeutics. The most heavily invested institutionals were Baker BROS. Advisors LP ($673.62M), BlackRock Inc. ($635.07M), Avoro Capital Advisors LLC ($581.61M), Vanguard Group Inc. ($487.69M), Price T Rowe Associates Inc. MD ($479.26M), Wellington Management Group LLP ($421.42M), and Atlas Venture Life Science Advisors LLC ($326.53M).Learn more on Kymera Therapeutics' institutional investors.

Of the 222 institutional investors that purchased Kymera Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BlackRock Inc. ($5.54M), Baker BROS. Advisors LP ($2.01M), Avoro Capital Advisors LLC ($1.77M), Wellington Management Group LLP ($1.69M), Vanguard Group Inc. ($1.32M), Price T Rowe Associates Inc. MD ($1.29M), and Holocene Advisors LP ($840.33K).

Institutional investors have bought a total of 20,694,980 shares in the last 24 months. This purchase volume represents approximately $1.83B in transactions.

Of the 71 institutional investors that sold Kymera Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Atlas Venture Life Science Advisors LLC ($2.05M), Wellington Management Group LLP ($1.17M), Jennison Associates LLC ($531.07K), T. Rowe Price Investment Management Inc. ($514.39K), AJU IB Investment Co. Ltd. ($437.41K), Marshall Wace LLP ($321.05K), and Alyeska Investment Group L.P. ($309.45K).

Institutional investors have sold a total of 8,727,687 shares in the last 24 months. This volume of shares sold represents approximately $732.74M in transactions.



Institutional ownership data for NASDAQ:KYMR is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 9/9/2026. New 13F filings are added each quarter as they're published.
From Our Partners